vimarsana.com

Page 27 - Cibc Private Wealth Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CIBC Private Wealth Group LLC Grows Stock Holdings in ResMed Inc (NYSE:RMD)

CIBC Private Wealth Group LLC raised its stake in ResMed Inc. (NYSE:RMD – Get Rating) by 99.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 294,948 shares of the medical equipment provider’s stock after acquiring an additional 147,355 shares during the period. CIBC […]

CIBC Private Wealth Group LLC Trims Holdings in Fidelity National Information Services, Inc (NYSE:FIS)

CIBC Private Wealth Group LLC reduced its holdings in shares of Fidelity National Information Services, Inc. (NYSE:FIS – Get Rating) by 28.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,265,484 shares of the information technology services provider’s stock after […]

CIBC Private Wealth Group LLC Buys 336,938 Shares of CoStar Group, Inc (NASDAQ:CSGP)

CIBC Private Wealth Group LLC boosted its holdings in CoStar Group, Inc. (NASDAQ:CSGP – Get Rating) by 38.8% in the fourth quarter, Holdings Channel reports. The firm owned 1,206,266 shares of the technology company’s stock after purchasing an additional 336,938 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in CoStar Group were worth […]

CIBC Private Wealth Group LLC Boosts Stake in AutoZone, Inc (NYSE:AZO)

CIBC Private Wealth Group LLC boosted its stake in AutoZone, Inc. (NYSE:AZO – Get Rating) by 1.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 26,612 shares of the company’s stock after buying an additional 386 shares during the quarter. CIBC Private Wealth […]

CIBC Private Wealth Group LLC Sells 749,600 Shares of Edwards Lifesciences Co (NYSE:EW)

CIBC Private Wealth Group LLC trimmed its position in Edwards Lifesciences Co. (NYSE:EW – Get Rating) by 39.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,166,847 shares of the medical research company’s stock after selling 749,600 shares during the quarter. […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.